Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)
This study has been completed.
Study NCT00399802   Information provided by Merck

First Received on November 14, 2006.   Last Updated on May 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Metastatic Bone Disease
Additional conditions recognized in this trial
Bone Diseases
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Odanacatib
Comparator: zoledronic acid
Comparator: Placebo (unspecified)
Additional drug interventions recognized in this trial
Diphosphonates
Zoledronic acid
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services